pyrenedodecanoylcarnitine has been researched along with Brain Injuries in 1 studies
*Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Bedoni, M; Carlomagno, C; Gualerzi, A; Haughey, NJ; Pal, A; Picciolini, S; Rais, R; Slusher, BS; Tallon, C; Thomas, AG; Yoo, SW | 1 |
1 other study(ies) available for pyrenedodecanoylcarnitine and Brain Injuries
| Article | Year |
|---|---|
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.
Topics: Animals; Brain Injuries; Carnitine; Corpus Striatum; Extracellular Vesicles; Injections, Intraventricular; Interleukin-1beta; Male; Mice; Mice, Transgenic; Microglia; Neurons; Oligodendroglia; Pyrenes; Sphingomyelin Phosphodiesterase | 2021 |